Mono Pharmacare Limited has informed the Exchange regarding 'Intimation for appointment of Additional Director (Non-Executive and Independent) on the Board of Directors of the Company under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.